文献速递系统性红斑狼疮血管炎

系统性红斑狼疮中肺动脉高压的患病率、危险因素和超声心动图预测因素:迈向筛查方案

Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
PubMed 文献 · RMD Open · 2024-01-08

这项前瞻性单中心研究纳入201例系统性红斑狼疮(SLE)患者,均接受经胸超声心动图检查。按欧洲心脏病学会(ESC)2022标准,16例(7.96%)为肺动脉高压(PH)中等或高概率,经右心导管检查确诊6例PH(患病率2.99%)和4例肺动脉高压(PAH,1.99%)。主要危险因素包括年龄、心肺症状、浆膜炎、抗Ro抗体、心脏生物标志物及肺功能检查异常。

要点

  • 201例SLE患者中7.96%超声心动图提示PH中等或高概率,右心导管确诊PH 2.99%、PAH 1.99%。
  • PH与较高SDI评分相关(均值4.75 vs 2.05,p<0.001),2年随访死亡率更高(12.50% vs 1.08%,p=0.002)。
  • 主要危险因素为年龄、心肺症状、浆膜炎、抗Ro抗体、心脏生物标志物及肺功能检查异常。

核心结论

  • 本队列中7.96%的SLE患者具有PH中等或高概率,经右心导管确诊6例(2.99%)符合ESC/欧洲呼吸学会PH标准、4例(1.99%)符合PAH标准。
  • PH是SLE的严重并发症,提示需要通过数据驱动的筛查实现更早期诊断,以降低相关发病率和死亡率。

研究设计与样本

  • 前瞻性单中心研究,纳入201例接受经胸超声心动图检查的SLE患者。
  • 符合PH标准的患者转诊接受右心导管检查。

主要发现

  • 患者中88.56%为女性,85.57%为西班牙裔,43.78%存在结构性心脏病。
  • 16例(7.96%)符合ESC 2022标准中PH中等或高概率标准。
  • 6例右心导管确诊PH,SLE-PH患病率2.99%,SLE-PAH患病率1.99%。
  • 主要危险因素包括年龄、心肺症状、浆膜炎、抗Ro抗体、心脏生物标志物及肺功能检查异常。
  • PH组SDI均值4.75 vs 非PH组2.05(p<0.001);2年随访死亡率12.50% vs 1.08%(p=0.002)。

关键数值与推荐

  • PH中等或高概率采用ESC 2022标准判定,16例(7.96%)符合。
  • PH确诊采用ESC/欧洲呼吸学会标准,右心导管确诊6例(2.99%);PAH确诊4例(1.99%)。

临床怎么用

  • 原文结论提示需要通过数据驱动的筛查实现SLE-PH更早期诊断,以降低相关发病率和死亡率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Systemic lupus erythematosus (SLE) significantly affects the lungs and heart, and pulmonary hypertension (PH) is a severe manifestation that leads to considerable morbidity and mortality. OBJECTIVES: We aimed to determine the prevalence and risk factors of probable SLE-PH, assess the main echocardiographic predictors and develop a potential screening strategy. METHODS: A prospective single-centre study was conducted on 201 patients with SLE who underwent transthoracic echocardiography. Patients meeting PH criteria were referred for right heart catheterisation (RHC). RESULTS: Among patients, 88.56% were women, 85.57% were of Spanish origin and 43.78% had structural heart disease. Out of these, 16 (7.96%) had intermediate or high probability criteria for PH according to European Society of Cardiology (ESC) 2022. Six RHCs confirmed PH with a prevalence of 2.99% for SLE-PH and 1.99% for SLE-pulmonary arterial hypertension (PAH). KEY RISK FACTORS: Key risk factors included age, cardiorespiratory symptoms, serositis, anti-Ro, cardiac biomarkers and altered pulmonary function tests (PFTs). PH was linked to a higher Systemic Lupus International Collaborative Clinics/American College of Rheumatology Damage Index (SDI) (mean SDI 4.75 vs 2.05, p<0.001) and increased mortality risk in a 2-year follow-up (12.50% vs 1.08%, p=0.002). CONCLUSION: In our cohort, 7.96% of patients with SLE had an intermediate or high PH probability. By RHC, six patients (2.99%) met the ESC/European Respiratory Society criteria for PH and four (1.99%) for PAH. The main risk factors were older age, cardiorespiratory symptoms, serositis, anti-Ro, cardiac biomarkers and altered PFTs. PH was a severe SLE complication, suggesting the need for earlier diagnosis through data-driven screening to reduce associated morbidity and mortality.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Álvarez Troncoso J, Soto Abánades C, Robles-Marhuenda Á, et al. Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol. RMD Open. 2024. PMID: 38191213. doi:10.1136/rmdopen-2023-003674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。